InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,615.35
(
0.55%
)
US TECH 100
19,804.00
(
0.64%
)
Dow Jones
40,000.90
(
0.62%
)
Brent Oil
84.57
(
0.00%
)
Bitcoin
58,677.28
(
1.36%
)
Post# of 252588
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

HobGlobulin

Send PM Follow Ignore
Followers 4
Posts 211
Boards Moderated 0
Alias Born 03/09/2007

HobGlobulin

Re: DewDiligence post# 62968

Wednesday, 05/28/2008 10:18:20 AM

Wednesday, May 28, 2008 10:18:20 AM

Post# of 252588
RE:SNUS merges with private firm, OncoGenex Technologies:

OncoGenex is pursuing cancer treatments using antisense licensed from Isis Pharmaceuticals. LLY is also developing antisense cancer treatments based on Isis IP.

First generation antisense had a lugubrious track record with regard to cancer (and virtually everything else.) It seems noteworthy that LLY is still aboard after the Affinitak debacle.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up